Abstract
One of the fundamental challenges facing the development of new chemical entities within the pharmaceutical industry is the extrapolation of key in vivo parameters from in vitro cell culture assays and animal studies. Development of microscale devices and screening assays incorporating primary human cells can potentially provide better, faster and more efficient prediction of in vivo toxicity and clinical drug performance. With this goal in mind, large strides have been made in the area of microfluidics to provide in vitro surrogates that are designed to mimic the physiological architecture and dynamics. More recent advancements have been made in the development of in vitro analogues to physiologically-based pharmacokinetic (PBPK) models - a mathematical model that represents the body as interconnected compartments specific for a particular organ. In this review we highlight recent advancements in human hepatocyte microscale culture, and describe the next generation of integrated devices, whose potential allows for the high throughput assessment of drug metabolism, distribution and pharmacokinetics.
Keywords: Microfluidics, human hepatocyte, bioreactor, coculture
Current Drug Metabolism
Title: Design and Application of Microfluidic Systems for In Vitro Pharmacokinetic Evaluation of Drug Candidates
Volume: 10 Issue: 10
Author(s): T. J. Maguire, E. Novik, P. Chao, J. Barminko, Y. Nahmias, M. L. Yarmush and K.-C. Cheng
Affiliation:
Keywords: Microfluidics, human hepatocyte, bioreactor, coculture
Abstract: One of the fundamental challenges facing the development of new chemical entities within the pharmaceutical industry is the extrapolation of key in vivo parameters from in vitro cell culture assays and animal studies. Development of microscale devices and screening assays incorporating primary human cells can potentially provide better, faster and more efficient prediction of in vivo toxicity and clinical drug performance. With this goal in mind, large strides have been made in the area of microfluidics to provide in vitro surrogates that are designed to mimic the physiological architecture and dynamics. More recent advancements have been made in the development of in vitro analogues to physiologically-based pharmacokinetic (PBPK) models - a mathematical model that represents the body as interconnected compartments specific for a particular organ. In this review we highlight recent advancements in human hepatocyte microscale culture, and describe the next generation of integrated devices, whose potential allows for the high throughput assessment of drug metabolism, distribution and pharmacokinetics.
Export Options
About this article
Cite this article as:
Maguire J. T., Novik E., Chao P., Barminko J., Nahmias Y., Yarmush L. M. and Cheng K.-C., Design and Application of Microfluidic Systems for In Vitro Pharmacokinetic Evaluation of Drug Candidates, Current Drug Metabolism 2009; 10 (10) . https://dx.doi.org/10.2174/138920009790820093
DOI https://dx.doi.org/10.2174/138920009790820093 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hypericin - The Facts About a Controversial Agent
Current Pharmaceutical Design Recent Progress in Chemosensors Using Aldehyde-bearing Fluorophores for the Detection of Specific Analytes and their Bioimaging
Current Medicinal Chemistry Age-Dependent Changes of the temporal Order - Causes and Treatment
Current Aging Science Metabolomics and the Diagnosis of Human Diseases -A Guide to the Markers and Pathophysiological Pathways Affected
Current Medicinal Chemistry Reverse Pharmacognosy: Another Way to Harness the Generosity of Nature
Current Pharmaceutical Design Incorporating Link Information in Feature Selection for Identifying Tumor Biomarkers by Using miRNA-mRNA Paired Expression Data
Current Proteomics MicroRNAs for Diagnosis and Treatment of Colorectal Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Application of Metabolomics in Drug Discovery, Development and Theranostics
Current Metabolomics Ketamine for Chronic Pain and Treatment Resistant Depression: A Mechanistic Hypothesis
Current Drug Therapy Targeting MAPK Signalling: Prometheus Fire or Pandoras Box?
Current Pharmaceutical Design Differences of Protein Fractions Among Fresh, Frozen and Powdered Donkey Milk
Recent Patents on Food, Nutrition & Agriculture Synthesis, Characterization, Anticancer and Antibacterial Activity of Some Novel Pyrano[2,3-d]pyrimidinone Carbonitrile Derivatives
Anti-Cancer Agents in Medicinal Chemistry Application of Chiral Bisamide Ligands in Asymmetric Catalytic Syntheses
Current Organic Synthesis Is There Anybody in There? On The Mechanisms of Wall Crossing of Cell Penetrating Peptides
Current Protein & Peptide Science Polyunsaturated Fatty Acids in Pathological Retinal Angiogenesis
Current Nutrition & Food Science Antioxidant Capacity and Identification of Bioactive Compounds by GC-MS of Essential Oils from Spices, Herbs and Citrus
Current Bioactive Compounds Membrane Transporters in Physiological Barriers of Pharmacological Importance
Current Pharmaceutical Design The Leptin System: A Potential Target for Sepsis Induced Immune Suppression
Endocrine, Metabolic & Immune Disorders - Drug Targets In Vitro and In Vivo Models for Analysis of Resistance to Anticancer Molecular Therapies
Current Medicinal Chemistry Simultaneous Electrochemical Determination of Vitamin K1 and Vitamin D3 by using Poly (Alizarin Red S)/Multi-walled Carbon Nanotubes Modified Glassy Electrode
Current Analytical Chemistry